Please provide your email address to receive an email when new articles are posted on . The FDA approved sutimlimab-jome infusion for the treatment of adults with a rare type of anemia.

Fanconi anemia is an aggressive, life-threatening disorder. Most individuals living with this rare genetic condition, characterized by bone marrow failure and cancer predisposition, survive into ...

Ferroportin is a protein that forms a channel for transporting iron in and out of cells. Ferroportin deficiency can be due to a genetic mutation or caused by inflammation or infection. Patients ...

The medication a doctor prescribes to treat anemia depends on the type of anemia a person has. For example, a person can take supplements to treat nutrient-deficiency anemia. More severe or chronic ...

Warm hemolytic anemia is a rare condition that affects your red blood cells. It causes anemia-like symptoms, such as fatigue, jaundice, and paleness. Share on Pinterest ZeynepKaya/Getty Images In warm ...

While anemia is not a typical symptom of IBS, people with IBS may develop anemia if they cannot absorb enough iron from their food. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder ...

Nicholas Kassebaum receives funding from the Bill & Melinda Gates Foundation. Theresa A McHugh and William Gardner do not work for, consult, own shares in or receive funding from any company or ...

Cirrhosis is a risk factor for anemia, and anemia can indicate worse cirrhosis outcomes. Cirrhosis may cause anemia, leading to red blood cell destruction, folate deficiency, or internal bleeding.

A Mother's Day blood drive was held Sunday in National City in honor of a baby with a rare form of anemia. Sevey Quinto, a 7-month-old baby, requires regular blood transfusions to stay alive. “We’re ...

Ferumoxytol, a novel intravenous form of iron that permits rapid administration of large doses, has been shown to be effective for treating iron deficiency in chronic kidney disease (CKD) patients on ...

Cambridge, Massachusetts-based Agios will market its new product, a twice-daily tablet, under the name “Pyrukynd.” The FDA’s Thursday approval covers use of the drug in adults who have an inherited ...